| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/02/2009 | US20090088389 Novel x-conotoxin peptides (-ii) |
| 04/02/2009 | US20090088385 immunoglobulins; fibronectins; drug screening |
| 04/02/2009 | US20090088384 Therapeutic Fibrin-Derived Peptides And Uses Thereof |
| 04/02/2009 | US20090088368 Compositions comprising them as ppar modulators |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | DE202009000358U1 Lokalanästhetikum zur Linderung von Brustschmerz Local anesthetic to relieve chest pain |
| 04/02/2009 | DE102007045476A1 Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 New heteroaryl acetone derivatives useful for inhibiting phospholipase A2 |
| 04/02/2009 | CA2709236A1 Pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | CA2700524A1 Alkylthio pyrimidines as crth2 antagonists |
| 04/02/2009 | CA2700365A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | CA2700274A1 Quinone derivatives, pharmaceutical compositions, and uses thereof |
| 04/02/2009 | CA2700267A1 Azacytidine analogues and uses thereof |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042513A1 Galectin 9-polymer conjugate |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042504A1 Fused azole-pyrimidine derivatives |
| 04/01/2009 | EP2042503A1 Compound having acidic group which may be protected, and use thereof |
| 04/01/2009 | EP2042499A1 Salt of morpholine compound |
| 04/01/2009 | EP2042495A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2042488A1 Matrix metalloproteinase inhibitors |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 04/01/2009 | EP2042172A1 Use of tocopherol derivatives as inhibitors of the notch signalling pathway |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2042164A1 Stabilized solid preparation |
| 04/01/2009 | EP2041338A1 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects |
| 04/01/2009 | EP2041151A1 A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material |
| 04/01/2009 | EP2041143A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
| 04/01/2009 | EP2041126A1 Indole compounds having affinity to the ep1 receptor |
| 04/01/2009 | EP2041118A1 Substituted heterocyclic compounds and methods of use |
| 04/01/2009 | EP2041117A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 04/01/2009 | EP2041116A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 04/01/2009 | EP2041107A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 04/01/2009 | EP2041094A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2041073A1 Cxcr2 inhibitors |
| 04/01/2009 | EP2041068A1 Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate |
| 04/01/2009 | EP2040758A2 Bioresponsive polymers |
| 04/01/2009 | EP2040726A1 Trachelospermi caulis extract composition for the treatment and prevention of inflammatory diseases |
| 04/01/2009 | EP2040705A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 04/01/2009 | EP2040699A2 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 04/01/2009 | EP2040549A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 04/01/2009 | EP1835926A4 Plasmin-inhibitory therapies |
| 04/01/2009 | EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 04/01/2009 | EP1572241B1 Oral pharmaceutical compositions comprising cyclosporin |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1126828B1 Oral administration of adenosine analogs |
| 04/01/2009 | CN201213639Y Fine Hurong bed clothes |
| 04/01/2009 | CN201213620Y Health-care medicine mattress |
| 04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 04/01/2009 | CN101397336A Antigenic Neisserial peptides |
| 04/01/2009 | CN101397330A Novel nitrogen-containing medicament with anti-inflammatory activity |
| 04/01/2009 | CN101397328A Nitric oxide-releasing glucocorticosteroid |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 04/01/2009 | CN101397294A N-substituted pyrrolidine derivates and uses thereof |
| 04/01/2009 | CN101397279A Method for preparing acanthus alkaloid A with anti inflammatory and analgesic activities and derivatives thereof |
| 04/01/2009 | CN101396551A Medicine capable of regulating ying and wei and treating arthralgia due to cold |
| 04/01/2009 | CN101396532A Jingu Fengshi Hantong paste |
| 04/01/2009 | CN101396528A Traditional Chinese medicine composite preparation for treating wind-heat cold |
| 04/01/2009 | CN101396499A Foot treatment medicine for treating arthralgia leg |
| 04/01/2009 | CN101396492A Quality control method for toxin ingredient, yunaconitine in Yuannan Hongyao capsule |
| 04/01/2009 | CN101396481A Medicine ointment for treating rheumatism |
| 04/01/2009 | CN101396452A Cold prevention medicine |
| 04/01/2009 | CN101396434A Method for separating total alkaloids from dactylicapnos root |
| 04/01/2009 | CN101396386A Extraction method of radix bupleuri |
| 04/01/2009 | CN101396382A Composite isatis root orally disintegrating tablet and preparation method thereof |
| 04/01/2009 | CN101396373A Cinobufacini extract and preparation method thereof |
| 04/01/2009 | CN101396371A Quality control method of Tibet crude-medicine processing material and new use thereof |
| 04/01/2009 | CN101396369A Pharmaceutical use of sophoricoside |
| 04/01/2009 | CN101396365A Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one |
| 04/01/2009 | CN101396345A Sinomenine hydrochloride sustained-released injection and preparation method thereof |
| 04/01/2009 | CN101396344A Paeonol microemulsion preparation and preparation method thereof |
| 04/01/2009 | CN101396335A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/01/2009 | CN100473417C Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511068 antiinflammatory agents |
| 03/31/2009 | US7511052 N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl)carbonyloxy}phenylalanine; antiinflammatory agent; asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2339792C Opthalmic solution with tetracycline for topical treatment of dry eye disease |
| 03/31/2009 | CA2328368C Anti-inflammatory agents |
| 03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
| 03/26/2009 | WO2009039310A2 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| 03/26/2009 | WO2009038812A1 Condensed piperidine derivatives useful as vanilloid receptor ligands |